Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors

Gastroenterology

Volumn 154, Issue 8, 2018, Pages 2152-2164.e19

  Jeon, Jihyoun ^a   Du, Mengmeng ^b   Schoen, Robert E ^c   Hoffmeister, Michael ^d   Newcomb, Polly A ^e   Berndt, Sonja I ^f   Caan, Bette ^g   Campbell, Peter T ^h   Chan, Andrew T ^i,j   Chang Claude, Jenny ^d   Giles, Graham G ^k   Gong, Jian ^e   Harrison, Tabitha A ^e   Huyghe, Jeroen R ^e   Jacobs, Eric J ^h   Li, Li ^l   Lin, Yi ^e   Le Marchand, Loïc ^m   Potter, John D ^e   Qu, Conghui ^e   Bien, Stephanie A ^e   Zubair, Niha ^e   Macinnis, Robert J ^k   Buchanan, Daniel D ^k,n,o   Hopper, John L ^n,p   Cao, Yin ⁱ   Nishihara, Reiko ⁱ   Rennert, Gad ^q   Slattery, Martha L ^r   Thomas, Duncan C ^s   Woods, Michael O ^t   Prentice, Ross L ^e   Gruber, Stephen B ^u   Zheng, Yingye ^e   Brenner, Hermann ^d   Hayes, Richard B ^v   White, Emily ^e   Peters, Ulrike ^e   Hsu, Li ^e   more..

^a UNIVERSITY OF MICHIGAN   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e USA   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g DIVISION OF RESEARCH   (United States)

^h AMERICAN CANCER SOCIETY   (Georgia)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k UNIVERSITY OF MELBOURNE   (Australia)

^l CASE WESTERN RESERVE UNIVERSITY   (United States)

^m UNIVERSITY OF HAWAII CANCER CENTER   (United States)

ⁿ UNIVERSITY OF MELBOURNE   (Australia)

^o ROYAL MELBOURNE HOSPITAL   (Australia)

^p Seoul National University   (South Korea)

^q CARMEL MEDICAL CENTER   (Israel)

^r UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^s UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^t MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^u UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^v NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Colon Cancer; Colonoscopy; CORECT; GECCO

Indexed keywords

ACCURACY; AGE; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CAUCASIAN; COLORECTAL CANCER; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HEREDITY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGICAL MODEL; COLONOSCOPY; COLORECTAL TUMOR; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; ENVIRONMENT; EVALUATION STUDY; GENETICS; MIDDLE AGED; PRACTICE GUIDELINE; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEX FACTOR; STANDARDS;

AGE FACTORS; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; ENVIRONMENT; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; ROC CURVE; SEX FACTORS;

EID: 85047736548     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2018.02.021     Document Type: Article

References (120)

1. American Cancer Society, Colorectal Cancer Facts & Figures 2014-2016. 2014, American Cancer Society, Atlanta, GA.
2. US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D.C., et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 315 (2016), 2564–2575.
3. US Preventive Services Task Force. Final Recommendation Statement: Colorectal Cancer: Screening, Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/colorectal-cancer-screening2. Published 2016. Accessed October 5, 2016.
4. National Center for Health Statistics. Table 72 (page 1 of 2). Use of colorectal tests or procedures among adults aged 50–75, by selected characteristics: United States, selected years 2000–2013. Available at: http://www.cdc.gov/nchs/hus/contents2015.htm#072. Published 2016. Accessed October 5, 2016.
5. Inadomi, J.M., Screening for colorectal neoplasia. N Engl J Med 376 (2017), 149–156.
6. Kho, A.N., Pacheco, J.A., Peissig, P.L., et al. Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med, 3, 2011, 79re1.
7. Chute, C.G., Kohane, I.S., Genomic medicine, health information technology, and patient care. JAMA 309 (2013), 1467–1468.
8. Ramsey, S., Blough, D., McDermott, C., et al. Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study. Public Health Genomics 13 (2010), 1–12.
9. Hsu, L., Jeon, J., Brenner, H., et al. A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology 148 (2015), 1330–1339.e14.
10. Drescher, C.W., Beatty, J.D., Resta, R., et al. The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: results from a randomized controlled trial. Cancer, 2016, 10.1002/cncr.30190.
11. Lieberman, D., Ladabaum, U., Cruz-Correa, M., et al. Screening for colorectal cancer and evolving issues for physicians and patients: a review. JAMA 316 (2016), 2135–2145.
12. Win, A.K., Macinnis, R.J., Hopper, J.L., Jenkins, M.A., Risk prediction models for colorectal cancer: a review. Cancer Epidemiol Biomarkers Prev 21 (2012), 398–410.
13. Dunlop, M.G., Tenesa, A., Farrington, S.M., et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut 62 (2013), 871–881.
14. Usher-Smith, J.A., Walter, F.M., Emery, J.D., Win, A.K., Griffin, S.J., Risk prediction models for colorectal cancer: a systematic review. Cancer Prev Res 9 (2016), 13–26.
15. Jeon, J., Meza, R., Hazelton, W.D., Renehan, A.G., Luebeck, E.G., Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis. Cancer Causes Control 26 (2015), 859–870.
16. Knudsen, A.B., Zauber, A.G., Rutter, C.M., et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force. JAMA 315 (2016), 2595–2609.
17. Ibáñez -Sanz, G., Diez-Villanueva, A., Alonso, M.H., et al. Risk model for colorectal cancer in Spanish population using environmental and genetic factors: results from the MCC-Spain study. Sci Rep, 7, 2017, 43263.
18. Murchie, B., Tandon, K., Hakim, S., et al. A new scoring system to predict the risk for high-risk adenoma and comparison of existing risk calculators. J Clin Gastroenterol 51 (2017), 345–351.
19. Cao, Y., Rosner, B.A., Ma, J., et al. Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy. Int J Cancer 137 (2015), 1719–1728.
20. Yeoh, K.G., Ho, K.Y., Chiu, H.M., et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 60 (2011), 1236–1241.
21. Hutter, C.M., Chang-Claude, J., Slattery, M.L., et al. Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res 72 (2012), 2036–2044.
22. Yuan, M., Lin, Y., Model selection and estimation in regression with grouped variables. J R Stat Soc B 68 (2006), 49–67.
23. Zanke, B.W., Greenwood, C.M., Rangrej, J., et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39 (2007), 989–994.
24. Tenesa, A., Farrington, S.M., Prendergast, J.G., et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 40 (2008), 631–637.
25. Houlston, R.S., Cheadle, J., Dobbins, S.E., et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet 42 (2010), 973–977.
26. Tomlinson, I.P., Carvajal-Carmona, L.G., Dobbins, S.E., et al. Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet, 7, 2011, e1002105.
27. Zhang, B., Jia, W.H., Matsuda, K., et al. Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk. Nat Genet 46 (2014), 533–542.
28. Peters, U., Bien, S., Zubair, N., Genetic architecture of colorectal cancer. Gut 64 (2015), 1623–1636.
29. Al-Tassan, N.A., Whiffin, N., Hosking, F.J., et al. A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer. Sci Rep, 5, 2015, 10442.
30. Schumacher, F.R., Schmit, S.L., Jiao, S., et al. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun, 6, 2015, 7138.
31. Zeng, C., Matsuda, K., Jia, W.H., et al. Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk. Gastroenterology 150 (2016), 1633–1645.
32. Peters, U., Jiao, S., Schumacher, F.R., et al. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology 144 (2013), 799–807.e24.
33. Hopper, J.L., Odds per adjusted standard deviation: comparing strengths of associations for risk factors measured on different scales and across diseases and populations. Am J Epidemiol 182 (2015), 863–867.
34. Krishnan, K., Baglietto, L., Apicella, C., et al. Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study. Breast Cancer Res, 18, 2016, 63.
35. Janes, H., Pepe, M.S., Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting. Am J Epidemiol 168 (2008), 89–97.
36. Surveillance Epidemiology and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2011 Sub (1973–2010). - Linked To County Attributes - Total U.S., 1969–2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission. Available at: http://www.seer.cancer.gov. Accessed November 10, 2017.
37. Gail, M.H., Brinton, L.A., Byar, D.P., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81 (1989), 1879–1886.
38. Rahman, R., Schmaltz, C., Jackson, C.S., et al. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States. Cancer Med 4 (2015), 1863–1870.
39. Ginsburg, G., Medical genomics: Gather and use genetic data in health care. Nature 508 (2014), 451–453.
40. Shirts, B.H., Salama, J.S., Aronson, S.J., et al. CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record. J Am Med Inform Assoc 22 (2015), 1231–1242.
41. Hartzler, A., McCarty, C.A., Rasmussen, L.V., et al. Stakeholder engagement: a key component of integrating genomic information into electronic health records. Genet Med 15 (2013), 792–801.
42. National Cancer Institute. Colorectal Cancer Risk Assessment Tool; 2014. Available at: https://www.cancer.gov/colorectalcancerrisk/. Accessed November 12, 2017.
43. Siteman Cancer Center. Your Disease Risk; 2013. Available at: http://yourdiseaserisk.wustl.edu/YDRDefault.aspx?ScreenControl=YDRGeneral&ScreenName=YDRcolon, Accessed November 12, 2017.
44. Brenner, H., Stock, C., Hoffmeister, M., Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ, 348, 2014, g2467.
45. Weigl, K., Jansen, L., Chang-Claude, J., et al. Family history and the risk of colorectal cancer: the importance of patients' history of colonoscopy. Int J Cancer 139 (2016), 2213–2220.
46. Taylor, D.P., Burt, R.W., Williams, M.S., et al. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology 138 (2010), 877–885.
47. Jiao, S., Peters, U., Berndt, S., et al. Estimating the heritability of colorectal cancer. Hum Mol Genet 23 (2014), 3898–3905.
48. Wei, Z., Wang, W., Bradfield, J., et al. Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease. Am J Hum Genet 92 (2013), 1008–1012.
49. Zheng Y, Hua X, Win AK, et al. Does a comprehensive family history of colorectal cancer improve risk prediction? In: Colditz G, Gapstur SM, Muir KR, et al, eds. Proceedings of An AACR Special Conference on Improving Cancer Risk Prediction for Prevention and Early Detection; November 16–19, 2016; Orlando, FL.
50. Zheng, C., Beresford, S.A., Van Horn, L., et al. Simultaneous association of total energy consumption and activity-related energy expenditure with risks of cardiovascular disease, cancer, and diabetes among postmenopausal women. Am J Epidemiol 180 (2014), 526–535.
51. Le Marchand, L., Hankin, J.H., Wilkens, L.R., et al. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 10 (2001), 1259–1266.
52. Calle, E.E., Rodriguez, C., Jacobs, E.J., et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 94 (2002), 2490–2501.
53. Brenner, H., Chang-Claude, J., Seiler, C.M., Rickert, A., Hoffmeister, M., Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 154 (2011), 22–30.
54. Lilla, C., Verla-Tebit, E., Risch, A., et al. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev 15 (2006), 99–107.
55. Slattery, M.L., Potter, J., Caan, B., et al. Energy balance and colon cancer—beyond physical activity. Cancer Res 57 (1997), 75–80.
56. Rimm, E.B., Stampfer, M.J., Colditz, G.A., et al. Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1 (1990), 466–473.
57. Giles, G.G., English, D.R., The Melbourne Collaborative Cohort Study. IARC Sci Publ 156 (2002), 69–70.
58. Kolonel, L.N., Henderson, B.E., Hankin, J.H., et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151 (2000), 346–357.
59. Poynter, J.N., Gruber, S.B., Higgins, P.D., et al. Statins and the risk of colorectal cancer. N Engl J Med 352 (2005), 2184–2192.
60. Belanger, C.F., Hennekens, C.H., Rosner, B., et al. The nurses' health study. Am J Nurs 78 (1978), 1039–1040.
61. National Cancer Institute. Cancer Genetic Markers of Susceptibility (CGEMS) data website.; 2010. Available at: http://soc.ics.uci.edu/Resources/collab.php?650. Accessed April 27, 2017.
62. Yeager, M., Chatterjee, N., Ciampa, J., et al. Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 41 (2009), 1055–1057.
63. Landi, M.T., Chatterjee, N., Yu, K., et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85 (2009), 679–691.
64. White, E., Patterson, R.E., Kristal, A.R., et al. VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol 159 (2004), 83–93.
65. Hays, J., Hunt, J.R., Hubbell, F.A., et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol 13 (2003), S18–S77.
66. Design of the Women's Health Initiative clinical trial and observational study, The Women's Health Initiative Study Group. Control Clin Trials 19 (1998), 61–109.
67. Bergstralh, E.J., Kosanke, J.L., Computerized matching of cases to controls. Tech Rep, 1995, 56.
68. Hutter, C.M., Chang-Claude, J., Slattery, M.L., et al. Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res 72 (2012), 2036–2044.
69. Thrift, A.P., Gong, J., Peters, U., et al. Mendelian randomization study of height and risk of colorectal cancer. Int J Epidemiol 44 (2015), 662–672.
70. Moghaddam, A.A., Woodward, M., Huxley, R., Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 16 (2007), 2533–2547.
71. Kantor, E.D., Hutter, C.M., Minnier, J., et al. Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci. Cancer Epidemiol Biomarkers Prev 23 (2014), 1824–1833.
72. Thrift, A.P., Gong, J., Peters, U., et al. Mendelian randomization study of body mass index and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 24 (2015), 1024–1031.
73. American Cancer Society, Colorectal Cancer Facts & Figures 2014-2016. 2014, American Cancer Society, Atlanta, GA.
74. Leufkens, A.M., Van Duijnhoven, F.J., Boshuizen, H.C., et al. Educational level and risk of colorectal cancer in EPIC with specific reference to tumor location. Int J Cancer 130 (2012), 622–630.
75. Doubeni, C.A., Laiyemo, A.O., Major, J.M., et al. Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study. Cancer 118 (2012), 3636–3644.
76. Larsson, S.C., Orsini, N., Wolk, A., Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97 (2005), 1679–1687.
77. Slattery, M.L., Physical activity and colorectal cancer. Sports Med 34 (2004), 239–252.
78. Botteri, E., Iodice, S., Bagnardi, V., et al. Smoking and colorectal cancer: a meta-analysis. JAMA 300 (2008), 2765–2778.
79. Liang, P.S., Chen, T.Y., Giovannucci, E., Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 124 (2009), 2406–2415.
80. Gong, J., Hutter, C., Baron, J.A., et al. A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors. Cancer Epidemiol Biomarkers Prev 21 (2012), 1974–1985.
81. Gong, J., Hutter, C.M., Newcomb, P.A., et al. Genome-wide interaction analyses between genetic variants and alcohol consumption and smoking for risk of colorectal cancer. PLoS Genet, 12, 2016, e1006296.
82. Cho, E., Smith-Warner, S.A., Ritz, J., et al. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140 (2004), 603–613.
83. Chubak J, Kamineni A, Buist DSM, et al. Aspirin use for the prevention of colorectal cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force. 2015;Report No.: 15-05228-EF-1.
84. Nan, H., Hutter, C.M., Lin, Y., et al. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA 313 (2015), 1133–1142.
85. Grodstein, F., Newcomb, P.A., Stampfer, M.J., Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 106 (1999), 574–582.
86. Garcia-Albeniz, X., Rudolph, A., Hutter, C., et al. CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. Br J Cancer 114 (2016), 221–229.
87. Giovannucci, E., Stampfer, M.J., Colditz, G.A., et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129 (1998), 517–524.
88. Suitor, C.W., Bailey, L.B., Dietary folate equivalents: interpretation and application. J Am Diet Assoc 100 (2000), 88–94.
89. Cho, E., Smith-Warner, S.A., Spiegelman, D., et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 96 (2004), 1015–1022.
90. Park, Y., Hunter, D.J., Spiegelman, D., et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 294 (2005), 2849–2857.
91. Chao, A., Thun, M.J., Connell, C.J., et al. Meat consumption and risk of colorectal cancer. JAMA 293 (2005), 172–182.
92. Koushik, A., Hunter, D.J., Spiegelman, D., et al. Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst 99 (2007), 1471–1483.
93. Kim, D.H., Smith-Warner, S.A., Spiegelman, D., et al. Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control 21 (2010), 1919–1930.
94. Figueiredo, J.C., Hsu, L., Hutter, C.M., et al. Genome-wide diet-gene interaction analyses for risk of colorectal cancer. PLoS Genet, 10, 2014, e1004228.
95. Du, M., Zhang, X., Hoffmeister, M., et al. No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 23 (2014), 2971–2976.
96. Ananthakrishnan, A.N., Du, M., Berndt, S.I., et al. Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies. Cancer Epidemiol Biomarkers Prev 24 (2015), 198–205.
97. Peters, U., Jiao, S., Schumacher, F.R., et al. Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology 144 (2013), 799–807.e24.
98. Houlston, R.S., Cheadle, J., Dobbins, S.E., et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet 42 (2010), 973–977.
99. Jia, W.H., Zhang, B., Matsuo, K., et al. Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat Genet 45 (2013), 191–196.
100. Dunlop, M.G., Dobbins, S.E., Farrington, S.M., et al. Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat Genet 44 (2012), 770–776.
101. Tomlinson, I.P., Webb, E., Carvajal-Carmona, L., et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 40 (2008), 623–630.
102. Tomlinson, I., Webb, E., Carvajal-Carmona, L., et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39 (2007), 984–988.
103. Zanke, B.W., Greenwood, C.M., Rangrej, J., et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39 (2007), 989–994.
104. Haiman, C.A., Le Marchand, L., Yamamato, J., et al. A common genetic risk factor for colorectal and prostate cancer. Nat Genet 39 (2007), 954–956.
105. Hutter, C.M., Slattery, M.L., Duggan, D.J., et al. Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis. BMC Cancer, 10, 2010, 670.
106. Kocarnik, J.D., Hutter, C.M., Slattery, M.L., et al. Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiol Biomarkers Prev 19 (2010), 3131–3139.
107. Tenesa, A., Farrington, S.M., Prendergast, J.G., et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 40 (2008), 631–637.
108. Tomlinson, I.P., Carvajal-Carmona, L.G., Dobbins, S.E., et al. Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet, 7, 2011, e1002105.
109. COGENT Study, Houlston, R.S., Webb, E., et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 40 (2008), 1426–1435.
110. Jaeger, E., Webb, E., Howarth, K., et al. Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet 40 (2008), 26–28.
111. Broderick, P., Carvajal-Carmona, L., Pittman, A.M., et al. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 39 (2007), 1315–1317.
112. Peters, U., Hutter, C.M., Hsu, L., et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet 131 (2012), 217–234.
113. Zhang, B., Jia, W.H., Matsuda, K., et al. Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk. Nat Genet 46 (2014), 533–542.
114. Wang, H., Burnett, T., Kono, S., et al. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. Nat Commun, 5, 2014, 4613.
115. Schumacher, F.R., Schmit, S.L., Jiao, S., et al. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun, 6, 2015, 7138.
116. Cui, R., Okada, Y., Jang, S.G., et al. Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population. Gut 60 (2011), 799–805.
117. Whiffin, N., Hosking, F.J., Farrington, S.M., et al. Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. Hum Mol Genet 23 (2014), 4729–4737.
118. Al-Tassan, N.A., Whiffin, N., Hosking, F.J., et al. A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer. Sci Rep, 5, 2015, 10442.
119. Zeng, C., Matsuda, K., Jia, W.H., et al. Identification of susceptibility loci and genes for colorectal cancer risk. Gastroenterology 150 (2016), 1633–1645.
120. Hopper, J.L., Odds per adjusted standard deviation: comparing strengths of associations for risk factors measured on different scales and across diseases and populations. Am J Epidemiol 182 (2015), 863–867.